330 related articles for article (PubMed ID: 27296640)
1. The Role of mGlu Receptors in Hippocampal Plasticity Deficits in Neurological and Psychiatric Disorders: Implications for Allosteric Modulators as Novel Therapeutic Strategies.
Senter RK; Ghoshal A; Walker AG; Xiang Z; Niswender CM; Conn PJ
Curr Neuropharmacol; 2016; 14(5):455-73. PubMed ID: 27296640
[TBL] [Abstract][Full Text] [Related]
2. Group I metabotropic glutamate receptor-mediated long term depression is disrupted in the hippocampus of WAG/Rij rats modelling absence epilepsy.
Di Cicco G; Marzano E; Iacovelli L; Celli R; van Luijtelaar G; Nicoletti F; Ngomba RT; Wall MJ
Neuropharmacology; 2021 Sep; 196():108686. PubMed ID: 34197893
[TBL] [Abstract][Full Text] [Related]
3. Differential activity of mGlu
Lin X; Fisher NM; Dogra S; Senter RK; Reed CW; Kalbfleisch JJ; Lindsley CW; Asher WB; Xiang Z; Niswender CM; Javitch JA
J Biol Chem; 2022 Oct; 298(10):102458. PubMed ID: 36063995
[TBL] [Abstract][Full Text] [Related]
4. Role of mGlu5 in Persistent Forms of Hippocampal Synaptic Plasticity and the Encoding of Spatial Experience.
Hagena H; Manahan-Vaughan D
Cells; 2022 Oct; 11(21):. PubMed ID: 36359749
[TBL] [Abstract][Full Text] [Related]
5. Neuropharmacological Insight from Allosteric Modulation of mGlu Receptors.
Stansley BJ; Conn PJ
Trends Pharmacol Sci; 2019 Apr; 40(4):240-252. PubMed ID: 30824180
[TBL] [Abstract][Full Text] [Related]
6. Allosteric Modulators of Metabotropic Glutamate Receptors as Novel Therapeutics for Neuropsychiatric Disease.
Luessen DJ; Conn PJ
Pharmacol Rev; 2022 Jul; 74(3):630-661. PubMed ID: 35710132
[TBL] [Abstract][Full Text] [Related]
7. Targeting metabotropic glutamate receptors for novel treatments of schizophrenia.
Maksymetz J; Moran SP; Conn PJ
Mol Brain; 2017 Apr; 10(1):15. PubMed ID: 28446243
[TBL] [Abstract][Full Text] [Related]
8. Chronic intermittent alcohol disrupts the GluN2B-associated proteome and specifically regulates group I mGlu receptor-dependent long-term depression.
Wills TA; Baucum AJ; Holleran KM; Chen Y; Pasek JG; Delpire E; Tabb DL; Colbran RJ; Winder DG
Addict Biol; 2017 Mar; 22(2):275-290. PubMed ID: 26549202
[TBL] [Abstract][Full Text] [Related]
9. Allosteric modulation of metabotropic glutamate receptors in alcohol use disorder: Insights from preclinical investigations.
Johnson KA; Lovinger DM
Adv Pharmacol; 2020; 88():193-232. PubMed ID: 32416868
[TBL] [Abstract][Full Text] [Related]
10. Identification of positive allosteric modulators VU0155094 (ML397) and VU0422288 (ML396) reveals new insights into the biology of metabotropic glutamate receptor 7.
Jalan-Sakrikar N; Field JR; Klar R; Mattmann ME; Gregory KJ; Zamorano R; Engers DW; Bollinger SR; Weaver CD; Days EL; Lewis LM; Utley TJ; Hurtado M; Rigault D; Acher F; Walker AG; Melancon BJ; Wood MR; Lindsley CW; Conn PJ; Xiang Z; Hopkins CR; Niswender CM
ACS Chem Neurosci; 2014 Dec; 5(12):1221-37. PubMed ID: 25225882
[TBL] [Abstract][Full Text] [Related]
11. On the Modulatory Roles of Neuregulins/ErbB Signaling on Synaptic Plasticity.
Ledonne A; Mercuri NB
Int J Mol Sci; 2019 Dec; 21(1):. PubMed ID: 31906113
[TBL] [Abstract][Full Text] [Related]
12. Metabotropic glutamate receptors as therapeutic targets for schizophrenia.
Vinson PN; Conn PJ
Neuropharmacology; 2012 Mar; 62(3):1461-72. PubMed ID: 21620876
[TBL] [Abstract][Full Text] [Related]
13. Neurobiological Insights from mGlu Receptor Allosteric Modulation.
O'Brien DE; Conn PJ
Int J Neuropsychopharmacol; 2016 May; 19(5):. PubMed ID: 26647381
[TBL] [Abstract][Full Text] [Related]
14. Allosteric Molecular Switches in Metabotropic Glutamate Receptors.
Orgován Z; Ferenczy GG; Keserű GM
ChemMedChem; 2021 Jan; 16(1):81-93. PubMed ID: 32686363
[TBL] [Abstract][Full Text] [Related]
15. Metabotropic glutamate receptors and cognition: From underlying plasticity and neuroprotection to cognitive disorders and therapeutic targets.
Hoglund BK; Carfagno V; Olive MF; Leyrer-Jackson JM
Int Rev Neurobiol; 2023; 168():367-413. PubMed ID: 36868635
[TBL] [Abstract][Full Text] [Related]
16. Fragment-Based Approaches for Allosteric Metabotropic Glutamate Receptor (mGluR) Modulators.
Orgován Z; Ferenczy GG; Keserű GM
Curr Top Med Chem; 2019; 19(19):1768-1781. PubMed ID: 31393248
[TBL] [Abstract][Full Text] [Related]
17. Recent Advances in the Modulation of Pain by the Metabotropic Glutamate Receptors.
Mazzitelli M; Presto P; Antenucci N; Meltan S; Neugebauer V
Cells; 2022 Aug; 11(16):. PubMed ID: 36010684
[TBL] [Abstract][Full Text] [Related]
18. Metabotropic Glutamate Receptors in Alcohol Use Disorder: Physiology, Plasticity, and Promising Pharmacotherapies.
Joffe ME; Centanni SW; Jaramillo AA; Winder DG; Conn PJ
ACS Chem Neurosci; 2018 Sep; 9(9):2188-2204. PubMed ID: 29792024
[TBL] [Abstract][Full Text] [Related]
19. Lead optimization of the VU0486321 series of mGlu
Davis DC; Bungard JD; Chang S; Rodriguez AL; Blobaum AL; Boutaud O; Melancon BJ; Niswender CM; Jeffrey Conn P; Lindsley CW
Bioorg Med Chem Lett; 2021 Jan; 32():127724. PubMed ID: 33253881
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of the Interaction Between Group I Metabotropic Glutamate Receptors and PDZ-Domain Proteins Prevents Hippocampal Long-Term Depression, but Not Long-Term Potentiation.
Neyman S; Braunewell KH; O'Connell KE; Dev KK; Manahan-Vaughan D
Front Synaptic Neurosci; 2019; 11():13. PubMed ID: 31057390
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
